Huifeng Bio-pharmaceutical Technology (fka HFGB)

[Ikem]

2008 EPS $0.08
2009 EPS $0.15
2010 EPS Estimate $0.20 - 0.25
Considering that they are usually conservative with their estimates couple with backlog. I think they are going to beat this estimate. Remember the second half of the year is the better half. I would not be surprise if they report EPS of $0.10 this quarter. I will continue to build position. I am not selling until I see the 2011 guidance. If it is anything north of $0.35, then I would not sell this under $4.00. The company is growing sales and making effort to dominate their space. The potential sales growth in europe is huge. I had my sell target $2.00 but that was before I saw this. www.hfgb.cn/doc/Huifeng_Investor_Presentation_-_August_5_2010.ppt